Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis

Author:

Ren Clement L.1ORCID,Morgan Rebecca L.2,Oermann Christopher3ORCID,Resnick Helaine E.4,Brady Cynthia5,Campbell Annette6,DeNagel Richard7,Guill Margaret8,Hoag Jeffrey9,Lipton Andrew10,Newton Thomas11,Peters Stacy12,Willey-Courand Donna Beth13,Naureckas Edward T.14

Affiliation:

1. Indiana University School of Medicine, Indianapolis, Indiana

2. McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada

3. Children’s Mercy–Kansas City, Kansas City, Missouri

4. Resnick, Chodorow, and Associates, Silver Spring, Maryland

5. Children’s Hospitals and Clinics of Minnesota, Saint Paul, Minnesota

6. Kansas City University of Medicine and Biosciences, Kansas City, Missouri

7. Patient Community Advisor, New York, New York

8. Dartmouth College Geisel School of Medicine, Hanover, New Hampshire

9. Drexel University College of Medicine, Philadelphia, Pennsylvania

10. Walter Reed National Military Medical Center, Bethesda, Maryland

11. Miller Children’s and Women’s Hospital Long Beach, Long Beach, California

12. South Dakota State University, College of Pharmacy, Brookings, South Dakota

13. University of Texas Health Science Center at San Antonio, San Antonio, Texas; and

14. University of Chicago, Chicago, Illinois

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3